Cooley advised Tenable on the deal. Tenable Holdings, Inc. (Nasdaq: TENB) announced that it has signed a definitive agreement to acquire Ermetic Ltd. for a purchase...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Cooley represent MindMed in connection with the proxy contest. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) has announced its successful proxy...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
You must be a Standard 1 Year member to access this content.
Cooley advised Intersect ENT on the deal, while Ropes & Gray advised Medtronic. Intersect ENT, a global ear, nose and throat medical technology leader dedicated to...
You must be a Standard 1 Year member to access this content.
